<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_BGU_Israel skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:BGU Israel</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>OriginALS</TITLE></P><DIV id="homePage"><P><TITLE>OriginALS</TITLE></P><DIV class="topnav" id="myTopnav"><A href="https://2018.igem.org/Team:BGU_Israel" id="brand-img"> </A><DIV id="topnav-right"><A href="https://2018.igem.org/Team:BGU_Israel">Home</A><DIV class="dropdown"><BUTTON class="dropbtn">Project
      </BUTTON><DIV class="dropdown-content"><A href="https://2018.igem.org/Team:BGU_Israel/Description	">Description</A><A href="https://2018.igem.org/Team:BGU_Israel/Design">Design</A><A href="https://2018.igem.org/Team:BGU_Israel/Experiments">Experiments</A><A href="https://2018.igem.org/Team:BGU_Israel/Results">Results</A><A href="https://2018.igem.org/Team:BGU_Israel/Demonstrate">Demonstrate</A></DIV></DIV><DIV class="dropdown"><BUTTON class="dropbtn">Lab
      </BUTTON><DIV class="dropdown-content"><A href="https://2018.igem.org/Team:BGU_Israel/Notebook">Notebook</A><A href="https://2018.igem.org/Team:BGU_Israel/Protocols">Protocols</A><A href="https://2018.igem.org/Team:BGU_Israel/InterLab">InterLab</A><A href="https://2018.igem.org/Team:BGU_Israel/Safety">Safety</A></DIV></DIV><DIV class="dropdown"><BUTTON class="dropbtn">Team
      </BUTTON><DIV class="dropdown-content"><A href="https://2018.igem.org/Team:BGU_Israel/Team">Members</A><A href="https://2018.igem.org/Team:BGU_Israel/Collaborations">Collaborations</A></DIV></DIV><DIV class="dropdown"><BUTTON class="dropbtn">Parts
      </BUTTON><DIV class="dropdown-content"><A href="https://2018.igem.org/Team:BGU_Israel/Parts">Overview</A><A href="https://2018.igem.org/Team:BGU_Israel/Basic_Part">Basic Parts</A><A href="https://2018.igem.org/Team:BGU_Israel/Part_Collection">Collection</A></DIV></DIV><DIV class="dropdown"><BUTTON class="dropbtn">Human Practices
      </BUTTON><DIV class="dropdown-content"><A href="https://2018.igem.org/Team:BGU_Israel/Human_Practices">Integrated Human Practices</A><A href="https://2018.igem.org/Team:BGU_Israel/ALSConference">ALS Conference</A><A href="https://2018.igem.org/Team:BGU_Israel/Public_Engagement">Public Engagement</A></DIV></DIV><DIV class="dropdown"><BUTTON class="dropbtn">Acknowledgements
      </BUTTON><DIV class="dropdown-content"><A href="https://2018.igem.org/Team:BGU_Israel/Attributions">Attributions</A><A href="https://2018.igem.org/Team:BGU_Israel/Sponsors">Sponsors</A></DIV></DIV><A href="javascript:void(0);" style="font-size:15px; " class="icon" onclick="myFunction()">☰</A></DIV></DIV></DIV><DIV id="abstract" class="bg-white text-center"><DIV class="row"><DIV class="col-sm-8"><H1>What we are all about</H1></DIV><DIV class="col-sm-4 display"><A href="https://2018.igem.org/Team:BGU_Israel/Description" class="btn btn-info" role="button">Learn More</A></DIV><DIV class="col-sm-8"><P class="mb-4 justified">Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease, is a devastating neurodegenerative disease that affects motor neurons in the central nervous system. Recent research studies of ALS suggest that brain cells that have become toxic, directly contribute to the progression of the disease. These cells change their gene expression pattern and possess distinguishing genetic markers. In addition, they drive the death of other cells in the brain among them the motor neurons. 
Our objective, as the BGU-IGEM team OriginALS, is to prolong survival of ALS patients via a novel genetic engineering approach. In order to reach this objective, we combine two separate strategies as our therapeutic approach: </P><OL class="justified"><LI> We identify and selectively eliminate only the toxic cells. In order to identify and target the toxic-cells only, we use distinguishing markers that are unique only to them.</LI><LI>We prevent the generation of new toxic cells by genetically targeting specific molecules that generate the toxic cells.</LI></OL><P class="mb-4 justified">
In conclusion, our approach combines an apoptotic destruction of toxic cells with the prevention of the formation of new toxic cells, thus aiming to significantly reduce the occurrence of toxic cells in the central neuronal system (CNS), which is aimed at a significant deceleration of the progression rate of ALS.</P></DIV></DIV></DIV></DIV><DIV id="video" class="container-fluid text-center"><DIV class="row"><DIV class="col-sm-8 col-sm-offset-2"><H1>Long Story Short</H1></DIV></DIV></DIV><TITLE>OriginALS</TITLE><FOOTER style="margin-bottom:-10px!important;margin-top:-10px!important;"><DIV class="container my-auto"><DIV class="row"><DIV class="col-md-4"><H3 style="color:white!important;">About Us</H3><P style="color:white!important;text-align: justify!important;">The BGU-iGEM team “OriginALS” hopes to develop an innovative therapeutic approach to prolong the life expectancy of ALS patients, using Synthetic Biology. We are dedicated to promoting ALS awareness and research in Israel through public engagement and educational activities.</P></DIV><DIV class="col-md-4"><UL class="footer-list"><H3>Keep in Touch</H3><LI class="footer-list-item"> @iGEMBGU</LI><LI class="footer-list-item">@igem_2018_bgu</LI><LI class="footer-list-item"> @originalsbgu</LI><LI class="footer-list-item"> originalsbgu@gmail.com</LI></UL></DIV><DIV class="col-md-4"><UL class="footer-list"><H3>Address</H3><LI class="footer-list-item">Ben-Gurion University of the Negev
Ben Gurion 1, Beer Sheva 8410501, Israel</LI></UL></DIV></DIV></DIV></FOOTER></DIV></DIV></DIV></DIV></BODY></HTML>